Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Lymphoma B-cell

Lymphoma B-cell

📧 Sign up to get email alerts when something new happens for Lymphoma B-cell.

Top drugs studied for this disease

nivolumab (2)
ASN002 (1)
CAR-T cell therapy targeting CD19 (fully-human anti-CD19 CAR) (1)
Zilovertamab (1)
CD19- and CD22-targeted CAR-T therapy (1)
90Y-hLL2 IgG (1)
Bexxar/BEAM (1)
Rituxan/BEAM (1)
CD19 and CD22-targeting CAR-T cells (1)
R (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms